Aurinia Pharmaceuticals Inc (AUPH)
5.085
+0.04
(+0.69%)
USD |
NASDAQ |
Apr 23, 16:00
5.085
0.00 (0.00%)
After-Hours: 18:15
Aurinia Pharmaceuticals Shareholders Equity (Quarterly): 377.95M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 377.95M |
September 30, 2023 | 391.88M |
June 30, 2023 | 392.29M |
March 31, 2023 | 390.41M |
December 31, 2022 | 405.44M |
September 30, 2022 | 423.42M |
June 30, 2022 | 423.77M |
March 31, 2022 | 448.12M |
December 31, 2021 | 479.09M |
September 30, 2021 | 298.17M |
June 30, 2021 | 332.26M |
March 31, 2021 | 370.23M |
December 31, 2020 | 407.75M |
September 30, 2020 | 398.84M |
June 30, 2020 | 239.04M |
March 31, 2020 | 263.41M |
December 31, 2019 | 298.60M |
September 30, 2019 | 123.74M |
June 30, 2019 | 125.87M |
March 31, 2019 | 139.34M |
December 31, 2018 | 112.58M |
September 30, 2018 | 125.34M |
June 30, 2018 | 142.17M |
March 31, 2018 | 152.45M |
December 31, 2017 | 165.74M |
Date | Value |
---|---|
September 30, 2017 | 167.64M |
June 30, 2017 | 178.46M |
March 31, 2017 | 172.66M |
December 31, 2016 | 35.95M |
September 30, 2016 | 20.10M |
June 30, 2016 | 19.54M |
March 31, 2016 | 16.02M |
December 31, 2015 | 19.96M |
September 30, 2015 | 23.54M |
June 30, 2015 | 28.01M |
March 31, 2015 | 27.56M |
December 31, 2014 | 33.87M |
September 30, 2014 | 49.32M |
June 30, 2014 | 51.07M |
March 31, 2014 | 54.62M |
December 31, 2013 | 13.31M |
September 30, 2013 | 12.23M |
June 30, 2013 | -2.894M |
March 31, 2013 | -2.921M |
December 31, 2012 | -2.118M |
September 30, 2012 | 2.208M |
June 30, 2012 | 3.772M |
March 31, 2012 | 6.157M |
December 31, 2011 | 6.411M |
September 30, 2011 | 12.47M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
123.74M
Minimum
Sep 2019
479.09M
Maximum
Dec 2021
346.86M
Average
390.41M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
Lexaria Bioscience Corp | 6.521M |
Acasti Pharma Inc | 64.68M |
Edesa Biotech Inc | 5.845M |
Xenon Pharmaceuticals Inc | 927.92M |
ESSA Pharma Inc | 140.68M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 548.06M |
Total Liabilities (Quarterly) | 170.11M |
Current Ratio | 5.503 |